Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Novel Outcomes in Calcium Fragmentation: Hertz Contact Intravascular Lithotripsy and PINNACLE I Outcomes
Author(s): Mirvat Alasnag , Stefan Verheye , Valeria Paradies Added: 7 months ago
Recorded at EuroPCR 2024 in Paris, these interviews provide insight into the Hertz Contact Intravascular Lithotripsy and PINNACLE I study. View more

Intervention
DynamX Bioadaptor RCT Two-Year Outcomes: Significant Advantages vs DES
Author(s): Shigeru Saito , Mirvat Alasnag Added: 7 months ago
Recorded at EuroPCR 2024 in Paris, these interviews provide insight into the Bioadaptor RCT trial. View more

Intervention
ADA 24: FLOW Trial: Kidney Outcomes in Patients Treated with Semaglutide
Author(s): Vlado Perkovic Added: 8 months ago
ADA 24 - In this succinct video, we are joined by Dr Vlado Perkovic (UNSW Sydney, Kensington, AU) to discuss a trial investigating the use of semaglutide in patients with type 2 diabetes and chronic kidney disease (NCT03819153).The FLOW trial enrolled 3533 participants with type 2 diabetes and chronic kidney disease, who were then randomized to recieve either semaglutide or placebo. The median… View more

Prevention & Chronic Conditions
AHA 24: New Insights from CLEAR OUTCOMES
Author(s): Marc P Bonaca Added: 3 months ago
AHA Conference 2024 - New insights from the CLEAR OUTCOMES trial investigating bempedoic acid (Esperion Therapeutics Inc.) in statin-intolerant patients with peripheral arterial disease (PAD).Dr Marc Bonaca (University of Colorado School of Medicine, Colorado, US) joins us onsite at AHA Conference to discuss new insights from CLEAR OUTCOMES (NCT02993406).CLEAR OUTCOMES is a double-blind,… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
HFA 24 Late-breaking Discussion: Findings from PACT-HF
Author(s): Harriette Van Spall , Tauben Averbuch Added: 10 months ago
HFA 2024 — Dr Tauben Averbuch and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the findings from the PACT-HF trial. In this analysis of PACT-HF, investigators looked at long term sex-specific clinical outcomes and healthcare resource utilisation following hospitalisation for heart failure at 5 years.Findings shows that clinical outcomes and overall costs were similar between… View more

Demographic

Heart Failure
ESC 24: The SCOFF Trial
Author(s): David Ferreira Added: 6 months ago
ESC Congress 24 — Fasting prior to cardiac catheterisation surgery significantly improves patient satisfaction score.We are joined onsite by Dr David Ferreira (John Hunter Hospital, AU) to discuss the findings from the SCOFF Trial (ACTRN12622001455752), which randomized 716 patients in a 1:1 fashion to either a no fasting group, or a fasting group. The fasting group were allowed solid foods 6… View more

Intervention
Navigating the Hybrid Approach and Optimising Patient Outcomes
Author(s): Syed Ahsan , Mark La Meir , Shibu Mathew Added: 1 year ago
Navigating the Hybrid Approach and Optimising Patient Outcomes is a comprehensive video series designed to equip healthcare professionals with the knowledge and skills necessary to excel in the field of hybrid ablation therapy. This innovative series will provide insights into patient criteria, enabling healthcare professionals to identify suitable candidates for this cutting-edge treatment and… View more

Electrophysiology & Arrhythmia
THT 25: The RELIEVE-HF Study
Author(s): Gregg Stone Added: 1 month ago
THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients. The study's prediction model revealed four independent predictors of two-year adverse outcomes in HFrEF patients treated with medical… View more

Heart Failure
CRT 25: 2Y Outcomes of Prevail Paclitaxel-Coated Balloon VS Contemporary DCB
Author(s): Sacharias Von Koch Added: 1 week ago
CRT 25 - Two-year outcomes of the Prevail paclitaxel-coated balloon show no difference in clinical outcomes compared to other drug-coated balloons (DCBs), suggesting the Prevail DCB is as effective and safe as other contemporary DCB's in a real-world setting. The Prevail DCB was also associated with lower rates of myocardial infarction in the sub-group analysis of patients who also underwent… View more

Intervention
Adopting Patient Reported Outcomes in Heart Failure Management
Author(s): Mikhail Kosiborod , Shelley Zieroth Added: 1 year ago
This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice. In this third and final discussion of the series, Dr Mikhail Kosiborod(Saint Luke’s Mid America Heart Institute, US) and Dr Shelley Zieroth (St Boniface Hospital, Winnipeg, CA)discuss the adoption of patient reported outcomes in… View more

Heart Failure